We contact authors of published studies to request for additional information, when needed, in order to accurately include their study in our evidence synthesis. Authors who have provided aggregated data of their studies are listed below.
Chaccour C. - The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial
Doi Y - A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19
Sigamani A. - Galectin Antagonist use in Mild Cases of SARS-CoV-2: Pilot Feasibility Randomised, Open Label, Controlled Trial
Abbaspour Kasgari H - Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial
Abd-Elsalam S - Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study
Ader F - An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-?-1a and hydroxychloroquine in hospitalized patients with COVID-19
Agarwal A - Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
Ahmed S - A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness
AlQahtani M - Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease
Altay O - Combined metabolic cofactor supplementation accelerates recovery in mild-tomoderate COVID-19
Amaravadi RK - Hydroxychloroquine for SARS-CoV-2 positive patients quarantined at home: The first interim analysis of a remotely conducted randomized clinical trial
Angus DC - Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19; The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial
Ansarin K - Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial
Araimo F - Ozone as adjuvant support in the treatment of COVID-19: A preliminary report of probiozovid trial
Avendano-Sola C - Convalescent Plasma for COVID-19: A multicenter, randomized clinical trial
Babalola OE - Ivermectin shows clinical benefits in mild to moderate COVID19: a randomized controlled double-blind, dose-response study in Lagos
Bajpai M - Efficacy of Convalescent Plasma Therapy compared to Fresh Frozen Plasma in Severely ill COVID-19 Patients: A Pilot Randomized Controlled Tria
Balcells M - Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial
Balykova L - New possibilities for targeted antiviral therapy for COVID-19. Results of a multi center clinical study of the efficacy and safety of using the drug Areplivir
Beigel JH - Remdesivir for the Treatment of Covid-19 ? Final Report
Borba MGS - Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical Trial
Brown SM - Hydroxychloroquine versus Azithromycin for Hospitalized Patients with COVID-19
Caleb P. Skipper - "Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19" - NCT04308668
Cavalcanti AB - Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
CCAP - Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia (CCAP)
Chang C - Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial
Chen CP - A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19)
Chen Jun - "Preliminary study of hydroxychloroquine sulfate in treating common coronavirus disease (COVID-19) patients in 2019" - NCT04261517
Chen L - Efficacy and safety of chloroquine or hydroxychloroquine in moderate type of COVID-19: a prospective open-label randomized controlled study
Chen P - SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Chen Z - Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial
Cheng L - Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID-19: An Open-Label Randomized Controlled Pilot Study
Chowdhury ATMM - A Comparative Study on Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin Therapy on COVID-19 Patients
COMIHY - Hydroxychloroquine for the Treatment of Mild COVID-19 Disease
Corral L - "USE OF CORTICOSTEROIDS IN PATIENTS WITH SARS-COV2 CORONAVIRUS INFECTION (GLUCOCOVID). Pragmatic trial inserted in real practice during a pandemic COVID-19" - EudraCT2020-001934-37
Corral-Gudino L - GLUCOCOVID: A controlled trial of methylprednisolone in adults hospitalized with COVID-19 pneumonia
COV-HCQ - Randomized Controlled Trial of Hydroxychloroquine Versus Placebo for the Treatment of Adult Patients With Acute Coronavirus Disease 2019 - COVID-19
Cruz LR - Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial
Dabbous HM - Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial
Davoodi L - Febuxostat therapy in outpatients with suspected COVID-19: A clinical trial
Davoudi-Monfared E - A Randomized Clinical Trial of the Efficacy and Safety of Interferon -1a in Treatment of Severe COVID-19
De Marchi T - Effects of photobiomodulation therapy combined with static magnetic field (PBMT-sMF) in patients with severe COVID-19 requiring intubation: a pragmatic randomized placebo-controlled trial
Deftereos S - Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019 The GRECCO-19 Randomized Clinical Trial
Delgado-Enciso I - Patient-Reported Health Outcomes After Treatment of COVID-19 with Nebulized and/or Intravenous Neutral Electrolyzed Saline Combined with Usual Medical Care Versus Usual Medical care alone: A Randomized, Open-Label, Controlled Trial.
Dequin P-F - Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19 A Randomized Clinical Trial
Dr. Reaz Mahmud - Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial
Duarte M - Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial
Dubee V - Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial
E. J. Giamarellos-Bourboulis - Early Anakinra Treatment for COVID-19 Guided by Urokinase Plasminogen Receptor
Edalatifiard M - Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial
Elgazzar A - Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic
Entrenas Castillo M - ?Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study?
Eric J. Lenze - Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19; A Randomized Clinical Trial
Esquivel-Moynelo - Effect and safety of combination of interferon alpha-2b and gamma or interferon alpha-2b for negativization of SARS-CoV-2 viral RNA. Preliminary results of a randomized controlled clinical trial
Fang Zheng - "A Novel Protein Drug, Novaferon, as the Potential Antiviral Drug for COVID-19" - ChiCTR2000029496
Farahani R - Evaluation of the Efficacy of Methylprednisolone Pulse Therapy in Treatment of Covid-19 Adult Patients with Severe Respiratory Failure: Randomized, Clinical Trial
Feld JJ - Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial
Fu W - An open-label, randomized trial of the combination of IFN-? plus TFF2 with standard care in the treatment of patients with moderate COVID-19
Furtado RHM - Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial
Garcia de Alencar JC - Double-blind, Randomized, Placebo-controlled Trial With N-acetylcysteine for Treatment of Severe Acute Respiratory Syndrome Caused by Coronavirus Disease 2019 (COVID-19)
George Sakoulas - "Study of Standard of Care Plus Intravenous Immunoglobulin (IVIG) Compared to Standard of Care Alone in the Treatment of COVID-19 Infection" - NCT04411667
Ghandehari S - Progesterone in Addition to Standard of Care Versus Standard of Care Alone in the Treatment of Men Admitted to the Hospital with Moderate to Severe COVID-19: A Randomised Control Phase 1 Trial
Gharbharan A - Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection
Gharebaghi N - The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial
Goldman JD - Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Gordon AC - Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19 The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Tria
Grieco DL - Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure The HENIVOT Randomized Clinical Trial
Guvenmez G - The comparison of the effectiveness of lincocin and azitro in the treatment of covid-19-associated pneumonia: A prospective study
Hernande-Cardenas C - Hydroxychloroquine Treatment for Severe COVID-19 Respiratory Disease: Randomised Clinical Trial (HYDRA Trial)
Hinks T - A randomised clinical trial of azithromycin versus standard care in ambulatory COVID19 ? the ATOMIC2 trial
Horby - Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby PW - Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Huang YQ - No Statistically Apparent Difference in Antiviral Effectiveness Observed Among Ribavirin Plus Interferon-Alpha, Lopinavir/Ritonavir Plus Interferon-Alpha, and Ribavirin Plus Lopinavir/Ritonavir Plus Interferon-Alpha in Patients With Mild to Moderate
Hung IF-N - Triple combination of interferon beta-1b, lopinavir?ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Ivan Fan-Ngai Hung - Triple combination of interferon beta-1b, lopinavir+ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Ivashchenko AA - AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial
Jagannathan P - Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial
Jason Stout - Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection
Johnston C - Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trial
Kalil A - Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
Khamis F - Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
Khan Chachar AZ - Effectiveness of Ivermectin in SARS-CoV-2/COVID-19 Patients
Kharat A - P59?Self-proning in COVID-19 patients on low-flow oxygen therapy. A cluster randomised controlled trial
Kirti R - Ivermectin as a potential treatment for mild to moderate COVID-19 ? A double blind randomized placebo-controlled trial
Koerper S - High Dose Convalescent Plasma in COVID-19: Results from the Randomized Trial CAPSID
Kumar S - A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19
Lanzoni G - Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial
Lemos ACB - Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)
Lescure FX - Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
Li C - Effect of a genetically engineered interferonalpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trial
Li L - Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19; A Randomized Clinical Trial
Li T - Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID-19: An Open-Label Randomized Controlled Pilot Study
Libster R - Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
Ling Li - "Convalescent plasma for the treatment of severe and critical novel coronavirus pneumonia (COVID-19): a prospective randomized controlled trial" - ChiCTR2000029757
Lopes M F - Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial
Lou Y - Clinical Outcomes and Plasma Concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 Patients: An Exploratory Randomized, Controlled Trial
Lyngbakken MN - A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics
Maldonado V - Pentoxifylline decreases serum LDH levels and increases lymphocyte count in COVID-19 patients: Results from an external pilot study
Marcus Vinicius Guimaraes de Lacerda - Phase IIb Study to Evaluate the Efficacy and Safety of Chloroquine Diphosphate in the Treatment of Patients With Comorbidities, Without Severe Acute Respiratory Syndrome, Under the New Coronavirus (SARS-CoV2): a Double-blind, Randomized, Placebo-cont
Maria Isabel F Lopes - "Beneficial effects of colchicine for moderate to severe COVID-19: an interim analysis of a randomized, double-blinded, placebo controlled clinical trial" - RBR-8jyhxh
Miller J - Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial
Mitja O - Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial
Monk PD - Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
Nojomi M - Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial
OAHU-COVID19 - A Randomized, Controlled Clinical Trial of the Safety and Efficacy of Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients
Okumu? N - Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients
Omrani A - Randomized double-blinded placebo-controlled trial of hydroxychloroquine with or without azithromycin for virologic cure of non-severe Covid-19
Perner A - Hydrocortisone for COVID-19 and Severe Hypoxia (COVID STEROID)
Podder C - Outcome of ivermectin treated mild to moderate COVID-19 cases: a single-centre, open-label, randomised controlled study
Pott-Junior H - Use of ivermectin in the treatment of Covid-19: A pilot trial
Prado Jeronimo CM - Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial
Prado Jeronimo CM - Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial
PROTECT - Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment
Rahmani H - Interferon β-1b in treatment of severe COVID-19: A randomized clinical trial
Rajasingham R - Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial
Ranjbar K - Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
Rastogi A - Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study)
Ray Y - Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial
Ren Z - A Randomized, Open-Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID-19, a Pilot Study
Riffat Mehboob - Aprepitant as a combinant with Dexamethasone reduces the inflammation via Neurokinin 1 Receptor Antagonism in severe to critical Covid-19 patients and potentiates respiratory recovery: A novel therapeutic approach
Rocco PRM - Early use of nitazoxanide in mild Covid-19 disease: randomised, placebo-controlled trial
Ronghua J - A multicenter, single-blind, randomized controlled clinical trial for chloroquine phosphate in the treatment of novel coronavirus pneumonia (COVID-19)
Roostaei A - Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial
Rosas I - Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
Ruzhentsova T - Phase 3 Trial of Coronavir (Favipiravir) in Patients with Mild to Moderate COVID-19
Sadeghi A - Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial
Sadeghipour P - Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit The INSPIRATION Randomized Cl
Salama C - Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Salehzadeh F - The Impact of Colchicine on The COVID-19 Patients; A Clinical Trial Study
Salvarani C - Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia A Randomized Clinical Trial
Samaha A - Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon
Self W - Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 A Randomized Clinical Trial
Shah Bukhari K H - Efficacy of Ivermectin in COVID-19 Patients with Mild to Moderate Disease
Shahbaznejad L - Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial
Shi L - Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial
Shogenova LV - Effect of thermal helium-oxygen mixture on viral load in COVID-19
Shu L - Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells
Shu-Hsing Cheng - "Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19" - NCT04384380
Siami Z - Effect of Ammonium Chloride in addition to standard of care in outpatients and hospitalized COVID-19 patients: A randomized clinical trial
Simonovich VA - A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
Skipper A - Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19; a randomized trial
Spinner CD - Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial
Stone JH - Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
Sultan Mehmood Kamran - "Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression (COVID-19)" - NCT04491994
Tabarsi P - Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial
Tang X - Early Use of Corticosteroid May Prolong SARS-CoV-2 Shedding in Non-Intensive Care Unit Patients with COVID-19 Pneumonia: A Multicenter, Single-Blind, Randomized Control Trial
Tomazini BM - Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19 The CoDEX Randomized Clinical Trial
Udwadia Z - Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial
Ulrich RJ - Treating COVID-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind Randomized Controlled Trial in Hospitalized Patients
Veiga VC - Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial
Villar J - Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial
Vlaar A.P.J - Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial
Wang D - Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial
Wang M - Treatment of Coronavirus Disease 2019 Patients With Prolonged Postsymptomatic Viral Shedding With Leflunomide: A Single-center Randomized Controlled Clinical Trial
Wang Y - Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Wei Tang - "Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial" - ChiCTR2000029868
Weinreich DM - REGEN-COV Antibody Cocktail Clinical Outcomes Study in Covid-19 Outpatients
Wu CN - High-flow nasal-oxygenation-assisted fibreoptic tracheal intubation in critically ill patients with COVID-19 pneumonia: a prospective randomised controlled trial
Wu X - Efficacy and Safety of Triazavirin Therapy for Coronavirus Disease 2019: A Pilot Randomized Controlled Trial
Yakoot M - Efficacy and Safety of Sofosbuvir/Daclatasvir in the Treatment of COVID-19: A Randomized, Controlled Study
Yang Cao - "Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial" - ChiCTR-OPN-2000029580
Yao-Kai Chen - "Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha and ribavirin plus lopinavir/ritonavir plus interferon-alphain in patients with mild to moderate novel coronavirus pneumonia" - ChiCTR
Yeming Wang - "Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial" - NCT04257656
Yethindra V - Efficacy of umifenovir in the treatment of mild and moderate COVID-19 patients
Yuan - Pulmonary radiological change of COVID-19 patients with 99mTc-MDP treatment
Yueping Li - "Efficacy and safety of lopinavir/ritonavir or arbidol in adult patients with mild/moderate COVID-19: an exploratory randomized controlled trial" - NCT04252885
Yueping Li - "The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection (ELACOI)" - NCT04252885
Zhang J - Pilot trial of high-dose vitamin C in critically ill COVID-19 patients
Zhao H - Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size
Zheng F - SARS-CoV-2 clearance in COVID-19 patients with Novaferon treatment: A randomized, open-label, parallel-group trial
Zhong M - A Randomized, Single-blind, Group sequential, Active-controlled Study to evaluate the clinical efficacy and safety of ?-Lipoic acid for critically ill patients with coronavirus disease 2019(COVID-19)